Literature DB >> 33456389

Vagus nerve stimulation: a pre-hospital case report.

Stian A Mohrsen1.   

Abstract

INTRODUCTION: Vagus nerve stimulation (VNS) is an adjunct therapy to anti-epileptics in patients where combination drug therapy alone has failed. The VNS device resembles an implantable defibrillator, and can be found underneath the clavicle on either side of the chest. By using a strong ring magnet, the device can be manipulated to seize function or operate on higher intensities, depending on how it is applied. The use of vagal stimulation is increasingly common and VNS is being explored for a range of other medical complaints. CASE: This case study discusses the encounter between a paramedic and a woman presenting with a choking sensation, isolated uvular deviation and stable cardiorespiratory functions. Following a short period of observation without adverse events, she was discharged on scene and advised to see her specialist epilepsy nurse.
CONCLUSION: Side effects of VNS increase with intensity of stimulation and can manifest throughout any branch of the vagus nerve. Its therapeutic mechanism of action is yet to be fully understood. The symptoms of over-stimulation are often frightening but benign, and although life-threatening events are rare, they require rapid recognition and immediate intervention.
© 2020 The Author(s).

Entities:  

Year:  2020        PMID: 33456389      PMCID: PMC7783950          DOI: 10.29045/14784726.2020.09.5.2.34

Source DB:  PubMed          Journal:  Br Paramed J        ISSN: 1478-4726


  18 in total

Review 1.  The chemical neuroanatomy of vagus nerve stimulation.

Authors:  Riccardo Ruffoli; Filippo S Giorgi; Chiara Pizzanelli; Luigi Murri; Antonio Paparelli; Francesco Fornai
Journal:  J Chem Neuroanat       Date:  2010-12-16       Impact factor: 3.052

2.  Single-center long-term results of vagus nerve stimulation for epilepsy: A 10-17 year follow-up study.

Authors:  Jan Chrastina; Zdeněk Novák; Tomáš Zeman; Jitka Kočvarová; Martin Pail; Irena Doležalová; Jiří Jarkovský; Milan Brázdil
Journal:  Seizure       Date:  2018-04-30       Impact factor: 3.184

Review 3.  Late-onset periodic bradycardia during vagus nerve stimulation in a pediatric patient. A new case and review of the literature.

Authors:  Verónica Cantarín-Extremera; María-Luz Ruíz-Falcó-Rojas; Amalia Tamaríz-Martel-Moreno; Marta García-Fernández; Anna Duat-Rodriguez; Belén Rivero-Martín
Journal:  Eur J Paediatr Neurol       Date:  2016-03-16       Impact factor: 3.140

4.  Mortality and SUDEP in epilepsy patients treated with vagus nerve stimulation.

Authors:  Claudia A Granbichler; Lina Nashef; Richard Selway; Charles E Polkey
Journal:  Epilepsia       Date:  2015-01-12       Impact factor: 5.864

Review 5.  Vagus nerve stimulation magnet activation for seizures: a critical review.

Authors:  R S Fisher; K S Eggleston; C W Wright
Journal:  Acta Neurol Scand       Date:  2014-08-22       Impact factor: 3.209

6.  Vagus nerve stimulation: outcome and predictors of seizure freedom in long-term follow-up.

Authors:  Kazem Ghaemi; Alaa Eldin Elsharkawy; Reinhard Schulz; Matthias Hoppe; Tilman Polster; Heinz Pannek; Alois Ebner
Journal:  Seizure       Date:  2010-04-01       Impact factor: 3.184

Review 7.  Vagus nerve stimulation therapy for seizures.

Authors:  Ramachandran Ramani
Journal:  J Neurosurg Anesthesiol       Date:  2008-01       Impact factor: 3.956

8.  Late-onset periodic asystolia during vagus nerve stimulation.

Authors:  Jorge Iriarte; Elena Urrestarazu; Manuel Alegre; Alfonso Macías; Asier Gómez; Paola Amaro; Julio Artieda; Cesar Viteri
Journal:  Epilepsia       Date:  2008-12-04       Impact factor: 5.864

9.  Long-term results of vagal nerve stimulation for adults with medication-resistant epilepsy who have been on unchanged antiepileptic medication.

Authors:  Eduardo García-Navarrete; Cristina V Torres; Isabel Gallego; Marta Navas; Jesús Pastor; R G Sola
Journal:  Seizure       Date:  2012-10-04       Impact factor: 3.184

Review 10.  Managing drug-resistant epilepsy: challenges and solutions.

Authors:  Linda Dalic; Mark J Cook
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.